Open AccessArticle High Prevalence of MRI Features of Mesenteric Panniculitis in Chronic Intestinal Inflammation: A Retrospective 3-T MRI Study 1 Institute for Diagnostic and Interventional Radiology/Neuroradiology, Westkuestenklinikum Heide, Academic Teaching Hospital of the Universities of Kiel, Luebeck and Hamburg, Esmarchstraße 50, 25746 Heide, Germany 2 Department of Orthopaedics, University Clinic for Orthopaedics and Trauma Surgery, Medical University of Vienna, Währinger Gürtel 18–20, 1090 Vienna, Austria 3 Department of Visceral, Thoracic and Vascular Surgery, Westkuestenklinikum Heide, Academic Teaching Hospital of the Universities of Kiel, Luebeck and Hamburg, Esmarchstraße 50, 25746 Heide, Germany * Author to whom correspondence should be addressed. Diagnostics 2026, 16(11), 1733; https://doi.org/10.3390/diagnostics16111733 (registering DOI) Submission received: 8 April 2026 / Revised: 18 May 2026 / Accepted: 26 May 2026 / Published: 4 June 2026 Abstract Background/Objectives: Mesenteric panniculitis (MP) is a chronic inflammatory and sclerosing disorder of the mesenteric fat. This study evaluated the occurrence and MRI appearance of MP in patients with chronic inflammatory bowel disease and chronic inflammatory bowel conditions. Methods: In this retrospective single-center study, 312 individuals underwent standardized 3-T MRI Sellink examinations, including 252 patients with clinically confirmed chronic inflammatory bowel disease or chronic inflammatory bowel conditions and 60 control patients without intestinal inflammation. MP was diagnosed when at least three of five characteristic MRI findings were present: increased mesenteric signal intensity on fat-saturated fluid-sensitive T2 sequences, fat ring sign, pseudocapsule, embedded micronodules, and displacement of bowel loops. Group differences were analyzed using contingency table analysis with Monte Carlo exact testing; Pearson’s chi-square test and Holm-adjusted pairwise post hoc comparisons were additionally performed. A p-value < 0.05 was considered statistically significant. Results: MRI signs of MP were present in 221/312 patients (70.8%) overall, including 220/252 patients (87.3%) in the disease cohort and 1/60 patients (1.7%) in the control group. Among patients with MP, the underlying diseases/conditions were Crohn’s disease (104/220, 47.3%), sigmoid diverticulitis (88/220, 40.0%), and ulcerative colitis (28/220, 12.7%). The overall distribution of MP extent differed significantly among diagnostic groups (Monte Carlo exact test: p = 0.030), although adjusted pairwise comparisons were not statistically significant. Topographically, MP showed a clear predominance in the left upper quadrant. Conclusions: MRI-defined features consistent with mesenteric panniculitis are highly prevalent in this selected cohort of patients with chronic intestinal inflammatory conditions when standardized criteria are applied. These findings suggest that MP-like mesenteric changes may represent a common imaging correlate of chronic intestinal inflammation rather than a rare incidental finding. MRI enables consistent detection and topographic assessment of MP. 1. Introduction Mesenteric panniculitis (MP) belongs to the spectrum of sclerosing mesenteritis, which has been discussed in relation to IgG4-associated fibroinflammatory disorders in parts of the literature [ 1, 2]. Histopathologically, MP is characterized by inflammatory cell infiltration, fat necrosis, and fibrosis of the mesenteric adipose tissue, with these three components occurring to varying degrees [ 3, 4, 5, 6]. In approximately 90% of cases, the root of the jejunal small-bowel mesentery represents the predominant site of involvement, whereas the mesocolon and mesoappendix are affected less frequently [ 7, 8]. Reported associated conditions include inflammatory, autoimmune, postoperative, and malignant processes [ 3, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16]. In addition, MP has been reported to be associated with breast cancer and multiple myeloma in women and with lymphoma in men [ 16]. Recent clinical and radiological case series have further emphasized the heterogeneous presentation of MP [ 17, 18], including atypical abdominal pain [ 19], persistent diagnostic uncertainty between benign inflammatory disease and malignancy [ 20], and FDG PET/CT appearances mimicking metastatic disease in a pediatric patient receiving immunotherapy [ 21]. On MRI, MP can be assessed using criteria analogous to those established in CT. Typically, it appears as a solid mesenteric mass, preferentially located along the mesenteric vessels, with intermediate to low signal intensity on T1-weighted images and high signal intensity on T2-weighted images [ 7, 31]. Areas of very low signal intensity on both T1- and T2-weighted sequences are attributable to fibrotic tissue components, which contain predominantly immobile protons with short T2 relaxation times [ 7]. In advanced retractile stages, the mesenteric mass may show a stellate configuration with radiating extensions and scattered punctate calcifications [ 7]. A fibrous pseudocapsule and the fat ring sign can be demonstrated both on CT and MRI and are helpful imaging features for distinguishing MP from malignant mesenteric processes [ 2, 7, 22, 32]. In addition, small nodules diffusely distributed throughout the affected mesentery may be present. In more advanced cases, mass effect with compression and displacement of adjacent small-bowel loops may occur, which can be well depicted on MRI. Owing to its high soft-tissue contrast, MRI also allows assessment of mesenteric vessels, which are often encased but usually not compressed by mesenteric masses; vascular complications may be suggested by absent flow-related signal on gradient-echo or fat-suppressed T1-weighted sequences [ 7]. Despite these established imaging features, the MRI phenotype of mesenteric panniculitis in the setting of chronic intestinal inflammatory disease has not been systematically characterized. The aim of the present study was therefore to evaluate the prevalence, imaging phenotype, and topographic distribution of mesenteric panniculitis in patients with clinically confirmed chronic inflammatory bowel disease and chronic inflammatory bowel conditions using standardized 3-T MRI criteria. 2. Materials and Methods 2.1. Study Design and Ethics This study was designed as a retrospective single-center analysis. Ethical approval was obtained from the Ethics Committee of the Medical Faculty of Christian-Albrechts-University Kiel (approval code: D 527/22). The primary endpoint was to assess the prevalence and MRI-based imaging characteristics of mesenteric panniculitis (MP) in patients with chronic inflammatory bowel disease or chronic inflammatory bowel conditions. Patients with a history of abdominal surgery or concomitant malignancy were excluded from the analysis. 2.3. MRI Protocol All examinations were performed as standardized MRI Sellink studies on a 3.0 T system (Achieva 3.0 T, Philips Healthcare, Hamburg, Germany). The protocol included coronal T2-SPAIR, coronal FFE, axial diffusion-weighted imaging, and axial T2-TSE sequences. After intravenous administration of butylscopolamine and gadolinium-DTPA, a coronal dynamic THRIVE sequence and axial contrast-enhanced T1-FFE-SPAIR sequences were acquired. 2.4. Image Analysis MRI datasets were pseudonymized and reviewed in a blinded fashion using identification numbers. Image analysis was performed retrospectively by a board-certified radiologist. A renewed pseudonymized re-evaluation of the datasets was additionally performed to assess the robustness of the MRI classification; this reassessment did not materially change the MP classification. MRI findings were considered consistent with MRI-defined MP when at least three of the following five predefined MRI criteria were present: Increased mesenteric signal intensity on fat-saturated fluid-sensitive T2 sequences in the early stage; A pseudocapsule with low signal intensity on T1- and T2-weighted images; Displacement of adjacent bowel loops; Embedded nodules; A fat ring sign around mesenteric vessels and nodules. Because increased T2 signal intensity on fat-suppressed sequences and displacement of adjacent bowel loops are nonspecific signs, these findings were not interpreted in isolation. Instead, diagnosis required a composite pattern of at least three MRI criteria, with particular attention to more specific morphological features such as a pseudocapsule, embedded nodules, and the fat ring sign. An example showing all five MRI features of mesenteric panniculitis is presented in Figure 1. In addition, MP localization and frequency were assigned to abdominal quadrants. 2.5. Statistical Analysis Statistical analyses were performed using SPSS version 23.0 (IBM Corp., Armonk, NY, USA). Categorical variables are presented as absolute and relative frequencies. Differences in the distribution of MP extent (3P, 4P, and 5P) among Crohn’s disease, ulcerative colitis, and recurrent sigmoid diverticulitis were analyzed using contingency table analysis. Because of partially low expected cell counts, Monte Carlo exact testing was used as the primary inferential method; Pearson’s chi-square test was additionally reported. Effect size was quantified using Cramér’s V. Pairwise post hoc comparisons were performed using 2 × 3 contingency tables with Holm correction for multiple testing. All tests were two-sided, and p-values < 0.05 were considered statistically significant. 4. Discussion The present study shows that MRI findings consistent with mesenteric panniculitis (MP) are highly prevalent in patients with chronic inflammatory bowel disease and related chronic inflammatory conditions undergoing standardized 3-T MRI Sellink examinations. In contrast, such findings were rare in the control group. Taken together, these observations support the interpretation that MP may represent a secondary mesenteric inflammatory response rather than merely an incidental finding in this specific patient population. Clinically, MP may be associated with nonspecific abdominal symptoms or may occur in parallel with symptoms attributable to the underlying gastrointestinal disease [ 34, 35]. A key finding of this study is the markedly higher prevalence of MRI-defined MP (87.3%) compared with previously reported rates of approximately 1–3% in predominantly CT-based cohorts [ 6, 8, 13, 22, 23, 24, 25, 26]. This discrepancy should be interpreted with caution. First, the present cohort represents a selected population consisting exclusively of patients with chronic inflammatory bowel disease or chronic inflammatory bowel conditions rather than an unselected imaging population; more generally, MP has been described in association with a broad spectrum of inflammatory, autoimmune, postoperative, and neoplastic conditions [ 3, 4, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16]. Second, the high soft-tissue contrast of 3-T MRI may facilitate detection of subtle mesenteric inflammatory abnormalities that may be less conspicuous on CT, and characteristic MRI features of MP have been described as largely analogous to CT findings [ 7, 31, 34]. Third, the application of predefined composite MRI criteria may increase sensitivity for imaging-based detection compared with less standardized assessment approaches [ 10, 34]. Importantly, increased mesenteric signal intensity on fat-saturated T2 sequences and displacement of bowel loops are nonspecific inflammatory or mass-effect signs and may contribute to overestimation if interpreted outside the full composite pattern. Therefore, the present results should be understood as the prevalence of MRI-defined features consistent with MP in a selected chronic inflammatory cohort, not as a histologically confirmed population prevalence of MP. Recent case series remain consistent with the broad clinical and radiological heterogeneity of MP, but they also show that contemporary cohorts are still small and therefore cannot resolve prevalence estimates in selected inflammatory populations [ 17, 18]. Accordingly, the prevalence observed in the present study should not be interpreted as a general population prevalence of MP and is not directly comparable to CT-based epidemiologic estimates [ 6, 8, 13, 22, 23, 24, 25, 26]. Although a statistically significant difference in the extent of MP was observed among Crohn’s disease, ulcerative colitis, and recurrent sigmoid diverticulitis, the corresponding effect size was small (Cramér’s V = 0.155) and adjusted pairwise comparisons were not statistically significant. This indicates that the observed group differences should be interpreted with caution and are unlikely to be of major clinical relevance. Accordingly, the present data do not support the conclusion that one specific disease entity is associated with a distinctly more pronounced MP pattern. The inclusion of patients with recurrent sigmoid diverticulitis also requires specific consideration. In this subgroup, MRI examinations reflected follow-up in symptomatic recurrence or a prolonged disease course rather than initial diagnostic imaging of first-time acute uncomplicated diverticulitis, for which CT is commonly used in clinical practice. The observed coexistence of recurrent diverticular inflammation and MP-compatible mesenteric changes is biologically plausible, but the retrospective design does not allow causal inference. Differences in clinical characteristics between diagnostic groups may provide additional insight into the pathophysiology of MP. Patients with recurrent sigmoid diverticulitis showed a significantly higher prevalence of diabetes mellitus and descriptively higher BMI values than patients with Crohn’s disease or ulcerative colitis. Previous studies have reported associations between MP, metabolic syndrome, and increased visceral as well as subcutaneous adipose tissue [ 36, 38]. Against this background, it appears plausible that systemic low-grade inflammation related to metabolic dysfunction may contribute to the development or extent of MP. However, because the control group was not formally matched for age, sex, or BMI, residual selection bias cannot be excluded. The topographical distribution of MP in the present study showed a clear predominance in the left upper quadrant, which is in line with previous reports [ 39]. This pattern may reflect anatomical or vascular characteristics of the mesenteric root, although the underlying mechanisms remain incompletely understood. MRI appears well suited for structured assessment of the extent, localization, and imaging phenotype of MP, particularly because of its high soft-tissue contrast and its ability to depict characteristic features such as mesenteric signal abnormalities, the hypointense pseudocapsule, embedded nodules, and displacement of adjacent bowel loops [ 10, 34]. In this context, MRI may complement the predominantly CT-based literature on MP by enabling a more detailed soft-tissue characterization. Limitations Several limitations of this study should be acknowledged. First, the retrospective single-center design may limit generalizability. Second, the control group was relatively small and was not formally matched to the disease cohort for age, sex, or BMI; therefore, selection bias related to age distribution, body habitus, or clinical referral patterns cannot be excluded. Third, diagnostic classification was based on clinical and imaging criteria without systematic histopathological confirmation. Fourth, image analysis was performed by a single radiologist, and inter-reader variability was not assessed, despite the partly subjective nature of MP diagnosis. Although a renewed pseudonymized reassessment did not materially change the classification, this does not replace formal independent multi-reader analysis. Fifth, systematic CT correlation was not part of the predefined study design. Interim CT examinations were available in a subset of patients and showed MP-compatible changes in individual cases, but no quantitative CT-MRI concordance analysis was performed. Sixth, serial MRI follow-up was not available in a standardized manner, so the study cannot determine whether the observed findings represent stable mesenteric panniculitis or transient inflammation-related mesenteric changes. Finally, the inclusion of recurrent sigmoid diverticulitis broadens the cohort beyond classical inflammatory bowel disease and should therefore be taken into account when interpreting disease-specific conclusions. In addition, the criteria-based MRI definition used in this study may have increased sensitivity for subtle mesenteric inflammatory changes because increased T2 signal intensity and bowel-loop displacement are nonspecific features; this may limit direct comparability with prior CT-based prevalence studies and with more restrictive definitions based only on pseudocapsule, embedded nodules, and the fat ring sign. 5. Conclusions MRI-defined features consistent with mesenteric panniculitis are frequent in patients with chronic intestinal inflammatory conditions undergoing standardized 3-T MRI Sellink examinations when predefined composite imaging criteria are applied. In this selected cohort, 220 of 252 patients (87.3%) fulfilled the MRI criteria for MP, whereas such findings were rare in controls. Although the overall distribution of MP extent differed significantly among diagnostic groups, no adjusted pairwise differences were observed. Overall, the findings suggest that MP-like mesenteric changes may represent a common imaging correlate of chronic intestinal inflammation. MRI enables structured detection and topographic assessment of MP and may complement CT-based characterization, but prospective studies with matched controls, multi-reader assessment, systematic CT correlation, and longitudinal follow-up are needed before clinical implications can be defined. Author Contributions Conceptualization, R.A.; investigation and data curation, V.T., J.R.A. and M.O.L.; writing—original draft preparation, V.T. and R.A.; supervision, C.K., F.S. and R.A.; statistical evaluation, J.R.A. All authors have read and agreed to the published version of the manuscript. Funding This research received no external funding. Institutional Review Board Statement This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Christian-Albrecht-University Kiel (approval code: D 527/22; date of approval: 6 September 2022). Informed Consent Statement Informed consent was obtained from all subjects involved in the study. Data Availability Statement The data presented in this study are available upon request from the corresponding author due to patient privacy concerns and ethical restrictions. Conflicts of Interest The authors declare no conflicts of interest. Abbreviations BMI Body mass index CRP C-reactive protein CT Computed tomography CU Ulcerative colitis DWI Diffusion-weighted imaging FFE Fast field echo Gd-DTPA Gadolinium-diethylenetriaminepentaacetic acid IBD Inflammatory bowel disease LLQ Left lower quadrant LUQ Left upper quadrant MRE Magnetic resonance enterography MRI Magnetic resonance imaging MP Mesenteric panniculitis n Number PACS Picture archiving and communication system RIS Radiology information system RLQ Right lower quadrant RUQ Right upper quadrant SPAIR Spectral attenuated inversion recovery T2-TSE T2-weighted turbo spin-echo T2-SPAIR T2-weighted SPAIR THRIVE T1 high-resolution isotropic volume examination References George, V.; Tammisetti, V.S.; Surabhi, V.R.; Shanbhogue, A.K. Chronic fibrosing conditions in abdominal imaging. Radiographics 2013, 33, 1053–1080. [ Google Scholar] [ CrossRef] Coulier, B. Mesenteric panniculitis. Part 2: Prevalence and natural course: MDCT prospective study. JBR-BTR 2011, 94, 241–246. [ Google Scholar] [ CrossRef] Horton, K.M.; Lawler, L.P.; Fishman, E.K. CT findings in sclerosing mesenteritis (panniculitis): Spectrum of disease. Radiographics 2003, 23, 1561–1567. [ Google Scholar] [ CrossRef] Scheer, F.; Kamusella, P.; Andresen, R. Exacerbated retractile mesenteritis—Rare case of abdominal pain. RöFo 2015, 187, 291–293. [ Google Scholar] [ CrossRef] Issa, I.; Baydoun, H. Mesenteric panniculitis: Various presentations and treatment regimens. World J. Gastroenterol. 2009, 15, 3827–3830. [ Google Scholar] [ CrossRef] Canyigit, M.; Koksal, A.; Akgoz, A.; Kara, T.; Sarisahin, M.; Akhan, O. Multidetector-row computed tomography findings of sclerosing mesenteritis with associated diseases and its prevalence. Jpn. J. Radiol. 2011, 29, 495–502. [ Google Scholar] [ CrossRef] Sabaté, J.M.; Torrubia, S.; Maideu, J.; Franquet, T.; Monill, J.M.; Pérez, C. Sclerosing mesenteritis: Imaging findings in 17 patients. Am. J. Roentgenol. 1999, 172, 625–629. [ Google Scholar] [ CrossRef] Akram, S.; Pardi, D.S.; Schaffner, J.A.; Smyrk, T.C. Sclerosing mesenteritis: Clinical features, treatment, and outcome in ninety-two patients. Clin. Gastroenterol. Hepatol. 2007, 5, 589–596. [ Google Scholar] [ CrossRef] Wilkes, A.; Griffin, N.; Dixon, L.; Dobbs, B.; Frizelle, F.A. Mesenteric panniculitis: A paraneoplastic phenomenon? Dis. Colon. Rectum. 2012, 55, 806–809. [ Google Scholar] [ CrossRef] Scheer, F.; Spunar, P.; Andresen, R. Persistent mesenteric panniculitis after cholecystectomy in chronic cholecystitis. RöFo 2016, 188, 89–91. (In German) [ Google Scholar] [ CrossRef] Hiridis, S.; Hadgigeorgiou, R.; Karakitsos, D.; Karabinis, A. Sclerosing mesenteritis affecting the small and the large intestine in a male patient with non-Hodgkin lymphoma: A case presentation and review of the literature. J. Med. Case Rep. 2008, 2, 388. [ Google Scholar] [ CrossRef] Rumman, N.; Rumman, G.; Sharabati, B.; Zagha, R.; Disi, N. Mesenteric panniculitis in a child misdiagnosed as appendicular mass: A case report and review of literature. Springerplus 2014, 3, 73. [ Google Scholar] [ CrossRef] Scheer, F.; Spunar, P.; Wiggermann, P.; Wissgott, C.; Andresen, R. Mesenteric Panniculitis (MP) in CT—A Predictor of Malignancy? RöFo 2016, 188, 926–932. [ Google Scholar] [ CrossRef] Mahafza, W.S.; Manzalawi, K.A.; Gharaibeh, A.A.; Khayat, O.W.; Shahait, A.; Juweid, M.E. Diagnosis of mesenteric panniculitis in the multi-detector computed tomography era. Association with malignancy and surgical history. Saudi Med. J. 2017, 38, 1013–1018. [ Google Scholar] [ CrossRef] Meyyur Aravamudan, V.; Khan, S.R.; Natarajan, S.K.; Hussain, I. The Complex Relationship between Mesenteric Panniculitis and Malignancy—A Holistic Approach is Still Needed to Understand the Diagnostic Uncertainties. Cureus 2019, 11, e5569. [ Google Scholar] [ CrossRef] Obeidat, N.; Al-Omari, M.; Fataftah, J.; AlQararha, K.; Al-Qaralleh, M. Mesenteric panniculitis: Is it really associated with cancer? A retrospective imaging-based study. Future Sci. OA 2025, 11, 2573615. [ Google Scholar] [ CrossRef] Wang, H.; Zhao, Z.; Cao, Q.; Ning, J. A review of 17 cases of mesenteric panniculitis in Zhengzhou Ninth People’s Hospital in China. BMC Gastroenterol. 2024, 24, 48. [ Google Scholar] [ CrossRef] Kerimoğlu, R.S.; Kargin, S.; Tanrikulu, Y.; Duyan, A.G.; Yilmaz, G. Mesenteric panniculitis: Radiological and clinical evaluation of 15 patients: A case series. Medicine 2025, 104, e45271. [ Google Scholar] [ CrossRef] Koumenis, A.; Manthas, A.; Piperos, T.; Mariolis-Sapsakos, T. Mesenteric Panniculitis Presenting With Atypical Abdominal Pain: A Case Report. Cureus 2025, 17, e91402. [ Google Scholar] [ CrossRef] Carneiro de Moura, J.F.; Rua, A. Sclerosing Mesenteritis: A Diagnostic Challenge Between Benignity and Malignancy. Cureus 2025, 17, e95567. [ Google Scholar] [ CrossRef] Farazmand, C.; Attaseth, P.; Zhuang, H. Mesenteric Panniculitis Mimicking Metastases From Melanoma on FDG PET/CT in a Pediatric Patient Receiving Immunotherapy. Clin. Nucl. Med. 2026, 51, 57–60. [ Google Scholar] [ CrossRef] Ege, G.; Akman, H.; Cakiroglu, G. Mesenteric panniculitis associated with abdominal tuberculous lymphadenitis: A case report and review of the literature. Br. J. Radiol. 2002, 75, 378–380. [ Google Scholar] [ CrossRef] Daskalogiannaki, M.; Voloudaki, A.; Prassopoulos, P.; Magkanas, E.; Stefanaki, K.; Apostolaki, E.; Gourtsoyiannis, N. CT evaluation of mesenteric panniculitis: Prevalence and associated diseases. Am. J. Roentgenol. 2000, 174, 427–431. [ Google Scholar] [ CrossRef] [ PubMed] Gögebakan, Ö.; Albrecht, T.; Osterhoff, M.A.; Reimann, A. Is mesenteric panniculitis truely a paraneoplastic phenomenon? A matched pair analysis. Eur. J. Radiol. 2013, 82, 1853–1859. [ Google Scholar] [ CrossRef] Emory, T.S.; Monihan, J.M.; Carr, N.J.; Sobin, L.H. Sclerosing mesenteritis, mesenteric panniculitis and mesenteric lipodystrophy: A single entity? Am. J. Surg. Pathol. 1997, 21, 392–398. [ Google Scholar] [ CrossRef] [ PubMed] Protin-Catteau, L.; Thiéfin, G.; Barbe, C.; Jolly, D.; Soyer, P.; Hoeffel, C. Mesenteric panniculitis: Review of consecutive abdominal MDCT examinations with a matched-pair analysis. Acta Radiol. 2016, 57, 1438–1444. [ Google Scholar] [ CrossRef] [ PubMed] Vlachos, K.; Archontovasilis, F.; Falidas, E.; Mathioulakis, S.; Konstandoudakis, S.; Villias, C. Sclerosing Mesenteritis: Diverse clinical presentations and dissimilar treatment options. A case series and review of the literature. Int. Arch. Med. 2011, 4, 17. [ Google Scholar] [ CrossRef] McLaughlin, P.D.; Filippone, A.; Maher, M.M. The “misty mesentery”: Mesenteric panniculitis and its mimics. Am. J. Roentgenol. 2013, 200, 116–123. [ Google Scholar] [ CrossRef] Yamamoto, K.; Honda, H.; Ogawa, H.; Otsuka, F. Key signs indicating mesenteric panniculitis. Clin. Case Rep. 2022, 10, e6654. [ Google Scholar] [ CrossRef] Sharma, P.; Yadav, S.; Needham, C.M.; Feuerstadt, P. Sclerosing mesenteritis: A systematic review of 192 cases. Clin. J. Gastroenterol. 2017, 10, 103–111. [ Google Scholar] [ CrossRef] Patel, R.K.; Mittal, S.; Singh, S. Imaging of Mischievous Intra-abdominal Fat Presenting with Abdominal Pain: A Pictorial Review. Euroasian J. Hepatogastroenterol. 2022, 12, 45–49. [ Google Scholar] [ CrossRef] Okino, Y.; Kiyosue, H.; Mori, H.; Komatsu, E.; Matsumoto, S.; Yamada, Y.; Suzuki, K.; Tomonari, K. Root of the small-bowel mesentery: Correlative anatomy and CT features of pathologic conditions. Radiographics 2001, 21, 1475–1490. [ Google Scholar] [ CrossRef] Leifeld, L.; Germer, C.T.; Böhm, S.; Dumoulin, F.L.; Frieling, T.; Kreis, M.; Meining, A.; Labenz, J.; Lock, J.F.; Ritz, J.P.; et al. S3-Leitlinie Divertikelkrankheit/Divertikulitis—Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV). Z. Gastroenterol. 2022, 60, 613–688. (In German) [ Google Scholar] [ CrossRef] Buragina, G.; Magenta Biasina, A.; Carrafiello, G. Clinical and radiological features of mesenteric panniculitis: A critical overview. Acta Biomed. 2019, 90, 411–422. [ Google Scholar] [ CrossRef] Azar, C.; Ibrahim, M.A.; El Kouzi, Z.; El Mokahal, A.; Omran, N.; Muallem, N.; Sharara, A.I. Mesenteric Panniculitis. Inflamm. Intest. Dis. 2024, 9, 157–164. [ Google Scholar] [ CrossRef] Gunes, S.O.; Akturk, Y.; Guldogan, E.S.; Yilmaz, K.B.; Ergun, O.; Hekimoglu, B. Association between mesenteric panniculitis and non-neoplastic disorders. Clin. Imaging 2021, 79, 219–224. [ Google Scholar] [ CrossRef] Dadkhah, A.; Jafari, S.; Bagheri, S.M.; Ebrahimi, A. Association between mesenteric panniculitis and urolithiasis. Emerg. Radiol. 2024, 31, 661–668. [ Google Scholar] [ CrossRef] Özer Gökaslan, Ç.; Aslan, E.; Demirel, E.; Yücel, A. Relationship of mesenteric panniculitis with visceral and subcutaneous adipose tissue. Turk. J. Med. Sci. 2020, 50, 44–48. [ Google Scholar] [ CrossRef] Sulbaran, M.; Chen, F.K.; Farraye, F.A.; Hashash, J.G. A Clinical Review of Mesenteric Panniculitis. Gastroenterol. Hepatol. 2023, 19, 211–218. [ Google Scholar] [ PubMed] Gögebakan, Ö.; Osterhoff, M.A.; Albrecht, T. Mesenteric Panniculitis (MP): A Frequent Coincidental CT Finding of Debatable Clinical Significance. RöFo 2018, 190, 1044–1052. [ Google Scholar] [ CrossRef] Figure 1. Axial T2-weighted MRI scan demonstrating a low-signal-intensity pseudocapsule, displacement of adjacent bowel loops, embedded nodules, a fat ring sign around mesenteric vessels and nodules, and reduced mesenteric signal intensity, consistent with MP. Figure 1. Axial T2-weighted MRI scan demonstrating a low-signal-intensity pseudocapsule, displacement of adjacent bowel loops, embedded nodules, a fat ring sign around mesenteric vessels and nodules, and reduced mesenteric signal intensity, consistent with MP. Figure 2. MRI findings in Crohn’s disease: ( a) axial MRI showing features of MP, including a pseudocapsule (red arrows), central signal reduction in the surrounding fatty tissue, embedded nodules with a halo sign, and displacement of adjacent bowel loops; ( b) axial MRI showing terminal ileitis with marked bowel wall thickening (blue arrows). Figure 2. MRI findings in Crohn’s disease: ( a) axial MRI showing features of MP, including a pseudocapsule (red arrows), central signal reduction in the surrounding fatty tissue, embedded nodules with a halo sign, and displacement of adjacent bowel loops; ( b) axial MRI showing terminal ileitis with marked bowel wall thickening (blue arrows). Figure 3. MRI findings in sigmoid diverticulitis: ( a) axial MRI showing mesenteric panniculitis with a distinct pseudocapsule and mass effect (red arrows); ( b) coronal MRI showing sigmoid diverticulitis with inflammatory bowel wall thickening (blue arrows). Figure 3. MRI findings in sigmoid diverticulitis: ( a) axial MRI showing mesenteric panniculitis with a distinct pseudocapsule and mass effect (red arrows); ( b) coronal MRI showing sigmoid diverticulitis with inflammatory bowel wall thickening (blue arrows). Figure 4. MRI findings in ulcerative colitis: ( a) axial and ( b) sagittal MRI showing MRI-defined MP with a pseudocapsule, embedded nodules/fat-ring configuration, and associated bowel-loop displacement/mass effect (red arrows); ( c) coronal MRI showing inflammatory wall thickening (blue arrows) of the descending colon. Figure 4. MRI findings in ulcerative colitis: ( a) axial and ( b) sagittal MRI showing MRI-defined MP with a pseudocapsule, embedded nodules/fat-ring configuration, and associated bowel-loop displacement/mass effect (red arrows); ( c) coronal MRI showing inflammatory wall thickening (blue arrows) of the descending colon. Figure 5. Grouped bar chart showing the proportion of mesenteric panniculitis (M.P.) extent across diagnostic groups. Bars represent the percentage of observations classified as 3P, 4P, or 5P within each disease category. Labels above bars indicate absolute counts and percentages. Total sample size for each diagnostic group is shown above the respective category. No 5P cases were observed in ulcerative colitis. Overall group differences were statistically significant (Monte Carlo p = 0.030), with a small effect size (Cramér’s V = 0.155). Figure 5. Grouped bar chart showing the proportion of mesenteric panniculitis (M.P.) extent across diagnostic groups. Bars represent the percentage of observations classified as 3P, 4P, or 5P within each disease category. Labels above bars indicate absolute counts and percentages. Total sample size for each diagnostic group is shown above the respective category. No 5P cases were observed in ulcerative colitis. Overall group differences were statistically significant (Monte Carlo p = 0.030), with a small effect size (Cramér’s V = 0.155). Figure 6. Schematic illustration of the localization and distribution of mesenteric panniculitis in the abdominal quadrants. Percentages for lower quadrants represent aggregated involvement based on multiquadrant distributions. Figure 6. Schematic illustration of the localization and distribution of mesenteric panniculitis in the abdominal quadrants. Percentages for lower quadrants represent aggregated involvement based on multiquadrant distributions. Table 1. Age of patients in the investigated diagnostic groups. Table 1. Age of patients in the investigated diagnostic groups. Diagnosis n Mean Age and Range (Years) Crohn’s disease 110 28.1 (18–38) Sigmoid diverticulitis 99 64.8 (38–77) Ulcerative colitis 43 38.8 (20–58) Table 2. Descriptive characteristics of the control group. Table 2. Descriptive characteristics of the control group. Parameter Value n 60 Age, mean (range) years 37.4 (18–45) Gender distribution 42 women, 18 men BMI, mean (range) kg/m 224.1 (17.1–28.4) Table 3. Clinical characteristics of patients with mesenteric panniculitis according to diagnostic group. Table 3. Clinical characteristics of patients with mesenteric panniculitis according to diagnostic group. Characteristic Crohn’s Disease Sigmoid Diverticulitis Ulcerative Colitis p-Value Diabetes mellitus 0/104 (0%) 49/88 (55.7%) 0/28 (0%) <0.001 BMI, mean (range), kg/m 223.7 (18.1–34.1) 27.9 (18.6–39.9) 24.1 (21.9–31.2) n.a. Smoking 40/104 (38.5%) 38/88 (43.2%) 5/28 (17.9%) 0.054 Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Share and Cite MDPI and ACS Style Tehranirad, V.; Andresen, J.R.; Liedke, M.O.; Kopetsch, C.; Scheer, F.; Andresen, R. High Prevalence of MRI Features of Mesenteric Panniculitis in Chronic Intestinal Inflammation: A Retrospective 3-T MRI Study. Diagnostics 2026, 16, 1733. https://doi.org/10.3390/diagnostics16111733 AMA Style Tehranirad V, Andresen JR, Liedke MO, Kopetsch C, Scheer F, Andresen R. High Prevalence of MRI Features of Mesenteric Panniculitis in Chronic Intestinal Inflammation: A Retrospective 3-T MRI Study. Diagnostics. 2026; 16(11):1733. https://doi.org/10.3390/diagnostics16111733 Chicago/Turabian Style Tehranirad, Vahidreza, Julian Ramin Andresen, Marc Olaf Liedke, Christoph Kopetsch, Fabian Scheer, and Reimer Andresen. 2026. "High Prevalence of MRI Features of Mesenteric Panniculitis in Chronic Intestinal Inflammation: A Retrospective 3-T MRI Study" Diagnostics 16, no. 11: 1733. https://doi.org/10.3390/diagnostics16111733 APA Style Tehranirad, V., Andresen, J. R., Liedke, M. O., Kopetsch, C., Scheer, F., & Andresen, R. (2026). High Prevalence of MRI Features of Mesenteric Panniculitis in Chronic Intestinal Inflammation: A Retrospective 3-T MRI Study. Diagnostics, 16(11), 1733. https://doi.org/10.3390/diagnostics16111733 Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here. Article Metrics Article metric data becomes available approximately 24 hours after publication online.
